On the recordJanuary 20, 2016
Madam President, I yield now to the ranking member of the Special Committee on Aging, my colleague Senator McCaskill. The PRESIDING OFFICER. The Senator from Missouri. Mrs. McCASKILL. Madam President, first I want to compliment the chairman of the committee for her remarks, which presented, I think, a very thorough and complete look at what the committee is doing and why we are doing it. There are different ways that people can do business in the Capitol. There is the one-off press conference, there is the topic of the day that everyone scurries to get attention for, and then there is the professional, plodding, complete investigation into a very important public policy issue. That is the kind of investigation that Chairman Collins is leading--one that is responsible, thorough, and, frankly, grounded in a deep belief that the American people have the right to know why these obscure drugs and the companies that developed them were purchased, and then they exploded in price. This is something we need to understand. These drugs are lifesaving drugs. This is something that adversely affects many Americans with these drugs. But the problem that is represented here could have much broader implications. Prescription drug prices have increased by 13 percent in 2015, and they are up 76 percent in the past 5 years--more than eight times the rate of inflation. A recent national poll shows that the affordability of prescription drugs was Americans' top health concern.…
Source
govinfo.gov




